News
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...
SHOPPING: Enter Hers , the company offering a streamlined and more accessible option - without insurance, appointments, and ...
A daily pill that works like Ozempic can help slimmers lose an average of two stone, trials have found. The study of ...
People taking the new wonder drug orforglipron lost an average of 12.4 per cent of their body weight after 72 weeks and ...
First ever daily Ozempic-like PILL helps users shed up to 2st – and could be available within months
A DAILY weight loss pill that works like Ozempic can help users shed an average of almost two stone, a study reveals. People ...
Wegovy, a brand name for semaglutide, is a GLP-1 inhibitor medication that targets the parts of the brain that regulate ...
Novo claims the defendants are steering patients toward compounded semaglutide that has not been approved by regulators; in ...
Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...
Originally developed to treat type 2 diabetes and medical obesity, GLP-1 receptor agonists like tirzepatide and semaglutide ...
23h
Investor's Business Daily on MSNNovo Nordisk Slumps As 'Unlawful' Knockoffs Pressure Wegovy, OzempicNovo Nordisk stock slumped Wednesday after saying it expects compounded versions to undercut sales of its obesity drug, ...
Novo Nordisk (NVO) offered investors an update about ongoing cost-cutting efforts as copycat weight-loss drugs weigh on sales ...
European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results